SNPs in the CYP2D6 (rs3892097), CAT (rs7943316 and rs1001179), and SLC14A1 (rs2298720) genes were found to be linked to reduced metabolism or the elimination of HU, which may increase its therapeutic effects in patients with SCA (Yahouedehou et al., 2020). The gene discussed is SLC14A1; the disease is autosomal dominant cerebellar ataxia.